You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia,%20Myeloid,%20Acute

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Acute Myeloid Leukemia Trial (Dasatinib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 20, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

      Not yet recruiting
      • AML
      • +11 more
      • (no location specified)
      Aug 14, 2023

      Frequency and Risk Factors of Acute Myeloid Leukemia

      Not yet recruiting
      • Myeloid Leukemia
      • Bone marrow aspirite for diagnosis
      • (no location specified)
      Mar 15, 2023

      Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Acute Myeloid Leukemia, in Relapse
      • anti Tim-3/CD123 CAR-T cell therapy
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Nov 4, 2023

      A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

      Not yet recruiting
      • C-KIT Mutation
        • (no location specified)
        Nov 2, 2023

        Acute Myeloid Leukemia Trial (ABBV-787)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • (no location specified)
        Sep 29, 2023

        Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Oral azacitidine
        • Seoul, Korea, Republic of
          Bristol-Myers Squibb YH
        Oct 3, 2023

        Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

        Recruiting
        • Acute Myeloid Leukemia
        • Beijing, Beijing, China
          Peking University People's Hospital
        Jun 23, 2023

        Acute Myeloid Leukemia Trial in Taipei

        Enrolling by invitation
        • Acute Myeloid Leukemia
          • Taipei, Taiwan
            National Taiwan University Hospital
          Aug 9, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • (no location specified)
          May 29, 2023

          Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

          Not yet recruiting
          • Acute Myeloid Leukemia, in Relapse
          • Acute Myeloid Leukemia Refractory
          • (no location specified)
          Nov 9, 2023

          Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Yuan Kong
          Sep 4, 2023

          Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

          Recruiting
          • Acute Myeloid Leukemia Refractory
          • Lyon, France
            Centre Léon Bérard
          Nov 30, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • Tianjin, China
            Institute of Hematology & Blood Diseases Hospital
          Jul 1, 2023

          PET Tracer Based FDG Signal for Predicting Prognosis in Acute

          Enrolling by invitation
          • Acute Myeloid Leukemia
          • No intervention
          • Guangzhou, Guangdong, China
            First Affiliated Hospital of Jinan University
          Jun 22, 2023

          Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

          Not yet recruiting
          • Chemotherapy-Induced Thrombocytopenia
          • Hetrombopag Olamine
          • (no location specified)
          Jul 5, 2023

          Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

          Not yet recruiting
          • Leukemia, Myeloid, Acute
          • BG1805
          • Guangzhou, Guangdong, China
          • +2 more
          Nov 1, 2023

          Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

          Recruiting
          • Acute Myeloid Leukemia
          • +3 more
          • CD123 targeted CAR-NK cells
          • Taiyuan, Shanxi, China
            Shanxi Bethune Hospital
          Aug 28, 2023

          iN the Real Practice

          Not yet recruiting
          • Acute Myeloid Leukemia (AML)
          • +2 more
          • Vyxeos liposomal
          • Roma, Italy
            Policlinico Tor Vergata
          Nov 16, 2023

          Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Houston, Texas
            MD Anderson Cancer Center
          Oct 27, 2023

          Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • High-Risk and Very High-Risk Myelodysplastic Syndromes
          • (no location specified)
          Jul 25, 2023

          Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

          Recruiting
          • Leukemia, Myeloid, Acute
          • Minimal Residual Disease
            • Chapel Hill, North Carolina
              North Carolina Cancer Hospital (NCCH)
            Feb 2, 2023

            Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

            Not yet recruiting
            • Acute Myeloid Leukemia
              • (no location specified)
              Sep 22, 2023